References

 

1.     Barker, D.J.P., Gluckman, P.D., Godfrey, K.M., Harding, J.E., Owens, J.A., and Robinson, J.S.,1993, Fetal nutrition and cardiovascular disease in adult life, Lancet,  341, 938.

2.    Hadders-Algra, M., and Touwen, B.C.,  1990, Body measurements, neurological and behavioral development in six year old children born premature and/or small-for-gestational-age, Early Hum. Dev., 22, 1.

3.   Perez-Escamilla, R., and Pollitt, E., 1992, Causes and consequences of intrauterine growth retardation in Latin America, Bull. Pan. Am. Health Organ.,   26, 128.

4.   Wolfe, H., and Gross, T.,  1989, Intrauterine growth retardation, Year Book Med. Publ., Chicago.

 

(To 10.1)

 

5.     Das, S., Sanyal, S., Banerjee, U., and Basu, K., 1998, Humoral immunity status in neonates born to preeclamptic toxaemia mothers, J. Indian Med. Assoc.,   96, 77.

6.      Yang, S.L., Lin, C.C., River, P., and Moawad, A.H., 1983, Immunoglobulin concentrations in newborn infants associated with intrauterine growth retardation, Obstet. Gynecol.,   62, 561.

7.      Henry, L., and Anderson, G., 1988-1989, Immunoglobulin-producing cells in the human thymus, Thymus,  12, 77.

8.      Henry, L., and Anderson, G., 1990, Immunoglobulins in Hassall's corpuscles of the human thymus, J.Anat.,   168,185. 

9.      Singh, M., Manerikar, S., Malaviya, A.N., Premawathi, P., Gopalan, R., and Kumar, R., 1978, Immune status of low birth weight babies, Indian Pediatr.,  15, 563.

10.    Ladipo, O.A., Salimonu, L.S., and Osunkoya, B.O., 1978, Correlation of birth weight with foeto-maternal immunoglobulin, total protein and albumin profile, Afr. J. Med. Sci.,  7, 211.

11.    Ueda, H., Nakanishi, A., and Ichijo, M., 1980, Immunoglobulins in newborns, particularly in term SFD infants, Tohoku J. Exp. Med.,   132, 31.

12.    Boersma, E.R., 1981, Serum immunoglobulins IgG, IgM, and IgA in maternal cord blood pairs from infants of normal and low birthweights in Tanzania, Arch. Dis. Child.,   56, 31.

 

(To 10.2)

13.    Garnica, A.D., and Chan, W.Y., 1996, The role of the placenta in fetal nutrition and growth, J. Am. Coll. Nutr.,  15, 206.

14.    Baschat, A.A., 2004, Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance, Obstet. Gynecol. Surv.,   59, 617. 

15.    Robinson, J., Chidzanja, S., Kind, K., Lok, F., Owens, P., and Owens, J., 1995, Placental control of fetal growth, Reprod. Fertil. Dev.,  7, 333.

16.    Iakovtsova, A.F., Sorokina, I.V., and Gargin, V.V., 1995, Morphologic features of immune interrelationships in the feto-placental system in development of a large fetus and in retardation of intrauterine fetal development, Arkh. Pathol. (Moscow),  57, 76.

17.    Labarrere, C., and Mullen, E., 1987, Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology, Am. J. Reprod. Immunol. Microbiol.,  15, 85.

18.    Henriksen, T., and Clausen, T., 2002, The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in well-nourished populations, Acta Obstet. Gynecol. Scand.,  81, 112. 

19.    Pijnenborg, R., 1996, The placental bed,  Hypertens. Pregnancy,   15, 7.

20.    Khong, T.Y., De Wolf, F., Robertson, W.B., and Brosens, I., 1986, Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants, Br. J. Obstet. Gynaecol.,  93, 1049.

21.    Salafia, C.M., Minior, V.K., Pezzullo, J.C., Popek, E.J., Rosenkrantz, T.S., and Vintzileos, A.M., 1995, Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: Associated placental pathologic features, Am. J. Obstet. Gynecol.,  173, 1049.

22.    Bauer, M.K., Harding, J.E., Bassett, N.S., Breier, B.H., Oliver, M.H., Gallaher, B.H., Evans, P.C., Woodall, S.M., and Gluckman, P.D., 1998, Fetal growth and placental function, Mol. Cell. Endocrinol., 140, 115. 

23.    Gluckman, P.D., and Pinal, C.S., 2002, Maternal-placental-fetal interactions in the endocrine regulation of fetal growth: role of somatotrophic axes, Endocrine,   19, 81.

24.    Regnault, T.R., Galan, H.L., Parker, T.A., and Anthony, R.V., 2002, Placental development in normal and compromised pregnancies - a review, Placenta, 23  Suppl A, S119. 

25.    Battistelli, M., Burattini, S., Pomini, F., Scavo, M., Caruso, A., and Falcieri, E., 2004, Ultrastructural study on human placenta from intrauterine growth retardation cases, Microsc. Res. Tech.,   65, 150. 

26.    Soma, H., Hata, T., Oguro, T., Fujita, K., Kudo, M., and Vaidya, U., 2005, Characteristics of histopathological and ultrastructural features of placental villi in pregnant Nepalese women, Med. Mol. Morphol.,   38, 92.

27.    Chaddha, V., Viero, S., Huppertz, B., and Kingdom, J.,  2004, Developmental biology of the placenta and the origins of placental insufficiency, Semin. Fetal Neonatal Med., 9, 357.

28.    Challier, J.C., and Uzan, S., 2003,The human placenta and its pathologies: focus on oxygen, Med. Sci. (Paris),  19,1111. 

29.    Huang, S.T., Vo, K.C., Lyell, D.J., Faessen, G.H., Tulac, S., Tibshirani, R., Giaccia, A.J., and Giudice, L.C., 2004, Developmental response to hypoxia, FASEB J., 18, 1348.

30.    Kajimura, S., Aida, K., and Duan, C., 2005, Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation, Proc. Natl. Acad. Sci. USA,  102, 1240.

31.    Dalcik, H., Yardimoglu, M., Vural, B., Dalcik, C., Filiz, S., Gonca, S., Kokturk, S., and Ceylan, S., 2001, Expression of insulin-like growth factor in the placenta of intrauterine growth-retarded human fetuses, Acta  Histochem.,  103, 195.

32.    Kohnen, G., Mackenzie, F., Collett, G.P., Campbell, S., Davenport, A.P., Cameron, A.D., and Cameron, I.T., 1997, Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies, Placenta,  18, 173.

33.    Erdem, M., Erdem, A., Erdem, O., Yildirim, G., Memis, L., and Himmetoglu, O., 2003, Immunohistochemical localization of endothelin-1 in human placenta from normal and growth-restricted pregnancies, Pediatr. Dev. Pathol., 6, 307.

34.    Rajashekhar, G., Loganath, A., Roy, A.C., and Wong, Y.C., 2003, Over-expression and secretion of angiogenin in intrauterine growth retardation placenta, Mol. Reprod. Dev.,   64, 397. 

35.    McTernan, C.L., Draper, N., Nicholson, H., Chalder, S.M., Driver, P., Hewison, M., Kilby, M.D., and Stewart, P.M., 2001, Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms, J. Clin. Endocrinol. Metab.,   86, 4979. 

36.    Jansson, T., and Powell, T.L.,  2000, Placental nutrient transfer and fetal growth, Nutrition, 16, 500.

37.    Gurevich, P., Elhayany, A., Ben-Hur, H., Moldavsky, M., Szvalb, S., Zandbank, J.,    Schneider, D.F., and  Zusman, I., 2003, Secretory Component, J Chain, and Immunoglobulins in human embryos and fetuses of the first trimester of pregnancy: Immunohistochemical study, Ped. Dev. Path., 6, 36.

38.    Billington, W.D., 1992, The normal fetomaternal immune relationship,  Baillieres Clin. Obstet. Gynaecol.,  6, 417.

39.    Blair, E., and Stanley, F., 1990, Intrauterine growth and spastic cerebral palsy. I. Association with birth weight for gestational age, Am. J. Obstet. Gynecol. 162, 229.

40.    Hales, C.N., and Barker, D.J., 1992, Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis, Diabetologia, 35, 595.  

41.    Schiff, E., Friedman, S.A., Baumann, P., Sibai, B.M.,   and Romero, R., 1994, Tumor necrosis factor- in pregnancies associated with preeclampsia or small-for-gestational-age newborns, Am. J. Obstet. Gynecol., 170, 1224.

42.    Linnemann, K., Malek, A., Schneider, H.,  and Fusch, C.,  2001, Physiological and pathological regulation of feto/placento/maternal leptin expression, Biochem. Soc. Trans., 29, 86. 

43.    Shigeta, K., Hiramatsu, Y., Eguchi, K.,   and Sekiba, K., 1992, Urinary and plasma epidermal growth factor levels are decreased in neonates with intrauterine growth retardation and in their mothers, Biol. Neonate, 62, 76.

44.    Evain-Brion, D., 1994, Hormonal regulation of fetal growth, Horm. Res., 42, 207.

45.    Abu-Amero, S.N., Ali, Z., Bennett, P., Vaughan, J.I., and Moore, G.E., 1998, Expression of the insulin-like growth factors and their receptors in term placentas: a comparison between normal and IUGR births, Mol. Reprod. Dev., 49, 229.

46.    Johnson, M.R., Anim-Nyame, N., Johnson, P., Sooranna, S.R., and Steer, P.J.,  2002, Does endothelial cell activation occur with intrauterine growth restriction? BJOG, 109, 836.

47.    Bartha, J.L., Romero-Carmona, R., and Comino-Delgado, R., 2003, Inflammatory cytokines in intrauterine growth retardation, Acta Obstet. Gynecol. Scand., 82, 1099.

48.    Harel, S., Somjen, D., Earon, Y., Tomer, A., Kaye, A.M., Kariv, N., and Binderman, I.,  1988, Vascular placental insufficiency in the rabbit. Changes in creatine kinase and adenylate kinase activities in fetal tissues, Biol. Neonate,  54, 116.

49.    Regnault, T.R., Friedman, J.E., Wilkening, R.B., Anthony, R.V., and Hay, W.W. Jr., 2005, Fetoplacental transport and utilization of amino acids in IUGR -a review, Placenta,  26 Suppl A, S52. 

50.    Jansson, T., Scholtbach, V., and Powell, T.L.,  1998, Placental transport of leucine and lysine is reduced in intrauterine growth restriction, Pediatr. Res.   44, 532.

51.    Mahendran, D., Donnai, P., Glazier, J.D., D’Souza, S.W., Boyd, R.D.H., and Sibley, C.P.,  1993, Amino acid (System A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies, Pediatr. Res., 34, 661.

52.    Jansson, T., Ylven, K., Wennergren, M., and Powell, T.L., 2002, Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction, Placenta,  23, 392. 

53.    Norberg, S., Powell, T.L., and Jansson, T.,  1998, Intrauterine growth restriction is associated with a reduced activity of placental taurine transporters, Pediatr. Res. 44, 233.

54.    Roos, S., Powell, T.L., and Jansson, T., , 2004, Human placental taurine transporter in uncomplicated and IUGR pregnancies: cellular localization, protein expression, and regulation, Am. J. Physiol. Regul. Integr. Comp. Physiol.,  287, R886.

55.    Anthony, R.V., Pratt, S.L., Liang, R., and Holland, M.D., 1995, Placental-fetal hormonal interactions: impact on fetal growth, J. Anim. Sci.,   73, 1861. 

56.    Steiner, H., Staudach, A., Spritzer, D., Schaffer, K.H., Gregg, A., and Weiner, C.P.,  1995, Growth deficient fetuses with absent or reversed umbilical artery end diastolic flow are metabolically compromised, Early Hum. Dev., 41, 1.

57.    Kulanthievel, P., Furesz, T.C., Moe, A.J., Smith, C.H., Mahesh, V.B., Leibach, F.H., and Ganapathy, V.,  1992, Human placental syncytiotrophoblast expresses two pharmacologically distinguishable types of Na+-H+ exchangers, NHE-1 in the maternal-facing (brush border) and NHE-2 in the fetal-facing (basal) membrane,  Biochem. J., 284, 33.

58.    Grassl, S.M.,  1989, Cl/HCO3 exchange in human placental brush border membrane vesicles, J. Biol. Chem., 264, 11103.

59.    Sardet, C., Franchi, A., and Pouyssegur, J.,  1989, Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+/H+ antiporter, Cell, 56, 21.

60.    Collins, J.F., Honda, T.S.K., Bulus, N.M., DuBois, R., and Ghishan, F.K., 1993, Molecular cloning, sequencing, tissue distribution, and functional expression of a Na+/H+ exchanger (NHE-2), Proc. Natl. Acad. Sci. USA, 90, 3938.

61.    Brant, S.R., Yun, C.H., Donowitz, M., and Tse, C.M., 1995, Cloning tissue distribution and functional analysis of the human Na+/H+ exchanger isoform  NHE3, Am. J. Physiol., 269, C198.

62.    Hughes, J.L., Doughty, I.M., Glazier, J.D., Powell, T.L., Jansson, T., D’Souza, S.W., and Sibley, C.P., 2000, Activity and expression of the Na+/H+ exchanger in the microvillous plasma membrane of the syncytiotrophoblast in relation to gestation and small for gestational age birth, Pediatr. Res., 48, 652.

63.    Pepe, G.J., Burch, M.G., Sibley, C.P., Davies, W.A., and Albrecht, E.D., 2001, Expression of the mRNAs and proteins for the Na(+)/H(+) exchangers and their regulatory factors in baboon and human placental syncytiotrophoblast, Endocrinol., 142, 3685.

64.    Fliegel, L., Haworth, R.S., and Dyck, J.R., 1993, Characterization of the placental brush border membrane Na+H+ exchanger: identification of thiol-dependent transitions in apparent molecular size, Biochem. J., 289,101.

65.    Powell, T.L., and Illsley, N.P., 1996, A novel technique for studying cellular function in human placenta: gestational changes in intracellular pH regulation, Placenta, 17, 661.

66.    Balkovetz, D.F., Leibach, F.H., Mahesh, V.B., Devoe, L.D., Cragoe, E.J. Jr., and Ganapathy, V., 1986, Na+/H+ exchanger of human placental brush-border membrane: identification and characterization, Am. J. Physiol., 251, C852.

67.    Glazier, J.D., Cetin, I., Perugino, G., Ronzoni, S., Grey, A.M., Mahendran, D., Marconi, A.M., Pardi, G., and Sibley, C.P., 1997, Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction, Pediatr. Res., 42, 514.

68.    Johansson, M., Glazier, J.D., Sibley, C.P., Jansson, T., and Powell, T.L., 2002, Activity and protein expression of the Na+/H+ exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies, J. Clin. Endocrinol. Metabolism,   87, 5686.

69.    Biemesderfer, D., Rutherford, R.A., Nagy, T., Pizzonia, J.H., Abu-Alfa, A.K., and Aronson, P.S., 1997, Monoclonal antibodies for high-resolution localization of NHE3 in adult and  neonatal rat kidney, Am. J. Physiol., 23, F289.

70.    Cavet, M.E., Akhter, S., deMedina, F.S., Donowitz, M., and Tse, C.M., 1999, Na+/H+ exchangers (NHE1–3) have similar turnover numbers but different percentages on the cell surface, Am. J. Physiol., 277, C1111.

71.    Wakabayashi, S., Shigekawa, M., and Pouyssegur, J.,  1997, Molecular physiology of vertebrate Na+/H+ exchangers, Physiol. Rev., 77, 51.

72.    Chow, C.W., 1999, Regulation and intracellular localization of the epithelial isoforms of the Na+/H+ exchangers NHE2 and NHE3, Clin. Invest. Med., 22, 195.

73.    Atkinson, D.E., Sibley, C.P., and Robinson, N.R., 1989, Amiloride reduces maternofetal clearance of sodium across the near-term rat placenta, Q. J. Exp. Physiol., 74, 557.

74.    Powell, T., Lundquist, C., Doughty, I.M., Glazier, J.D., and Jansson, T., 1998, Mechanisms of chloride transport across the syncytiotrophoblast basal membrane in the human placenta, Placenta, 19, 315.

75.    Thwaites, D.T., Kennedy, D.J., Raldua, D., Anderson, C.M.H., Mendoza, M.E., Bladen, C.L., and Simmons, N.L., 2002, H+/dipeptide absorption is controlled indirectly via a functional Na+/H+ exchanger, Gastroenterology, 122,1322.

76.    Balkovetz, D.F., Leibach, F.H., Mahesh, V.B., and Ganapathy, V., 1988, A proton gradient is the driving force for uphill transport of lactate in human placental brush border membrane vesicles, J. Biol. Chem., 263, 13823.

77.    Ganapathy, V., Ganapathy, M.E., Nair, C.N., Mahesh, V.B., and Leibach, F.H., 1988, Evidence for an organic cation-proton antiport system in brush-border membranes isolated from the human term placenta, J. Biol. Chem., 263, 4561.

78.    Meredith, D., and Laynes, R.W., 1996, Dipeptide transport in brush border membrane vesicles (BBMV) prepared from human full-term placentae, Placenta, 17, 173.

79.    Lucena, N., Silva, C.L., Wang, H., Harris, C.V., Singh, D., and Fliegel, L., 1997, Characterization of the Na+/H+ exchanger in human choriocarcinoma (BeWo) cells, Pflugers Arch., 433, 792.

80.    Nicolaides, K.H., Economides, D.L., and Soothill, P.W., 1989, Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses, Am. J. Obstet. Gynecol., 161, 996.

81.    Marchand, M.C., and Langley-Evans, S.C.,  2001, Intrauterine programming of nephron number: the fetal flaw revisited, J. Nephrol., 14, 327.

82.    Jansson, T., Wennergren, M., and Illsley, N.P.,  1993, Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation,  J. Clin. Endocrinol. Metab.,.  77, 1554.

83.    Langdown, M.L., and Sugden, M.C.,  2001, Enhanced placental GLUT1 and GLUT3 expression in dexamethasone-induced fetal growth retardation, Mol. Cell. Endocrinol.,  185, 109.

 

(To 10.3)

84.    Mahajan, S.D., Singh, S., Shah, P., Gupta, N., and Kochupillai, N., 2004, Effect of maternal malnutrition and anemia on the endocrine regulation of fetal growth,  Endocr. Res.,    30, 189.

85.       Resnik, R., 2002, Intrauterine growth restriction, Obstet. Gynecol., 99, 490.

86.    Prada, J.A., and Tsang, R.C., 1998, Biological mechanisms of environmentally induced causes of IUGR, Eur. J. Clin. Nutr.,   52 Suppl 1, S21.

87.    Wu, G., Bazer, F.W., Cudd, T.A., Meininger, C.J., and Spencer, T.E., 2004, Maternal nutrition and fetal development, J. Nutrition,  134, 2169. 

88.    Lindblad, B., Zaman, S., Malik, A., Martin, H., Ekstrom, A.M., Amu, S., Holmgren, A., and Norman, M., 2005, Folate, vitamin B12, and homocysteine levels in South Asian women with growth-retarded fetuses, Acta. Obstet. Gynecol. Scand.,    84, 1055. 

89.    Ronnenberg, A.G., Goldman, M.B., Chen, D., Aitken, I.W., Willett, W.C., Selhub, J., and Xu, X., 2002, Preconception homocysteine and B vitamin status and birth outcomes in Chinese women, Am. J. Clin. Nutr.,  76, 1385.

90.    Rondo, P.H., Abbott, R., Rodrigues, L.C., and Tomkins, A.M., 1995, Vitamin A, folate, and iron concentrations in cord and maternal blood of intra-uterine growth retarded and appropriate birth weight babies, Eur. J. Clin. Nutr., 49, 391.

91.    Scholl, T.O., Hediger, M.L., Schall, J.I., Khoo, C.S., and Fischer, R.L., 1996, Dietary and serum folate: their influence on the outcome of pregnancy, Am. J. Clin. Nutr.,   63, 520.

92.    Ghebremeskel, K., Burns, L., Burden, T.J., Harbige, L., Costeloe, K., Powell, J.J., and Crawford, M., 1994, Vitamin A and related essential nutrients in cord blood: relationships with anthropometric measurements at birth, Early Hum. Dev.,   39, 177.

93.    Lee, B.E., Hong, Y.C., Lee, K.H., Kim, Y.J., Kim, W.K., Chang, N.S., Park, E.A., Park, H.S., and Hann, H.J., 2004, Influence of maternal serum levels of vitamins C and E during the second trimester on birth weight and length, Eur. J. Clin. Nutr.,   58, 1365. 

94.    Maher, J.E. 3rd, Goldenberg, R.L., Tamura, T., Cliver, S.P., Johnston, K.E., and Hoffman, H.J., 1993, Indicators of maternal nutritional status and birth weight in term deliveries, Obstet. Gynecol.,  81, 165.

95.    Tamura, T., Goldenberg, R.L., Johnston, K.E., and DuBard, M., 2000, Maternal plasma zinc concentrations and pregnancy outcome, Am. J. Clin. Nutr., 71, 109. 

96.    Osada, H., Watanabe, Y., Nishimura, Y., Yukawa, M., Seki, K., and Sekiya S., 2002, Profile of trace element concentrations in the feto-placental unit in relation to fetal growth, Acta Obstet. Gynecol. Scand.,    81,  931. 

97.    Simmer, K., and Thompson, R.P., 1985, Maternal zinc and intrauterine growth retardation, Clin. Sci. (Lond),  68, 395.

98.    Neggers, Y.H., Goldenberg, R.L., Tamura, T., Cliver, S.P., and Hoffman, H.J., 1997, The relationship between maternal dietary intake and infant birthweight,  Acta Obstet. Gynecol. Scand.,   165 (Suppl.), 71.

99.    Hillier, S.L., Krohn, M.A., Kiviat, N.B., Watts, D.H., and Eschenbach, D.A., 1991, Microbiologic causes and neonatal outcomes associated with chorioamnion infection,  Am. J. Obstet. Gynecol., 165, 955.

100.  Romero, R., Mazor, M., Brandt, F., Sepulveda, W., Avila, C., Cotton, D.B., and Dinarello, C.A., 1992, Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition, Am. J. Reprod. Immunol., 27, 117.

101.  Hillier, S.L., Witkin, S.S., Krohn, M.A., Watts, D.H., Kiviat, N.B., and Eschenbach, D.A., 1993, The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection, Obstet. Gynecol., 81,  941.

102.  Saji, F., Samejima, Y., Kamiura, S., Sawai, K., Shimoya, K., and Kimura, T., 2000, Cytokine production in chorioamnionitis, J. Reprod. Immunol., 47, 185.

103.  Jaekle, R.K., Lutz, P.D., Rosenn, B., Siddiqi, T.A., and Myatt, L., 1994, Nitric oxide metabolites and preterm pregnancy complications, Am. J. Obstet. Gynecol., 171, 1115.

104.  Hsu, C.D., Meaddough, E., Aversa, K., Hong, S.F., Lee, I.S., Bahodo-Singh, R.O., Lu, L.C., and Copel, J.A., 1998, Dual roles of amniotic fluid nitric oxide and prostaglandin E2 in preterm labor with intra-amniotic infection, Am. J. Perinatol., 15, 683.

105.  Romero, R., Emamian, M., Wan, M., Quintero, R., Hobbins, J.C., and Mitchell, M.D., 1987, Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor, Am. J. Obstet. Gynecol., 157, 1461.

106.  Nakatsuka, M., Asagiri, K., Kimura, Y., Kamada, Y., Tada, K., and Kudo, T., 1999, Generation of peroxynitrite and apoptosis in placenta of patients with chorioamnionitis: possible implications in placental abruption, Hum. Reprod., 14, 1101.

107.  Gravett, M.G., Hitti, J., Hess, D.L., and Eschenbach, D.A., 2000, Intrauterine infection and preterm delivery: evidence for activation of the fetal hypothalamic–pituitary–adrenal axis, Am. J. Obstet. Gynecol., 182, 1404.

108.  Mulder, E.J., and Visser, G.H., 1992, Impact of early growth delay on subsequent fetal growth and functional development: a study on diabetic pregnancy, Early Hum. Dev.,   31, 91.

109.  Lang, U., Baker, R.S., Braems, G., Zygmunt, M., Kunzel, W., and Clark, K.E., 2003, Uterine blood flow - a determinant of fetal growth, Eur. J. Obstet. Gynecol. Reprod. Biol.,  110 (Suppl. 1), S55. 

110.  Warkentin, B., 1994, Fetal development in late gestosis and nicotine consumption, Geburtshilfe Frauenheilkd.,   54, 262.

111.  Odegard, R.A., Vatten, L.J., Nilsen, S.T., Salvesen, K.A., and Austgulen, R., 2000, Preeclampsia and fetal growth, Obstet. Gynecol.,   96, 950. 

112.  Florio, P., Ciarmela, P., Luisi, S., Palumbo, M.A., Lambert-Messerlian, G., Severi, F.M., and Petraglia, F., 2002, Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels, Gynecol. Endocrinol.,  16, 365. 

113.  D'Anna, R., Baviera, G., Corrado, F., Crisafulli, A., Ientile, R., Buemi, M., and Squadrito, F., 2004, Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction, BJOG,   111, 1046. 

114.  Siddiqi, T.A., Miodovnik, M., Mimouni, F., Clark, E.A., Khoury, J.C., and Tsang, R.C., 1989, Biphasic intrauterine growth in insulin-dependent diabetic pregnancies, J. Am. Coll. Nutr.,    8, 225.

115.  Langer, O., Kozlowski, S., and Brustman, L., 1991, Abnormal growth patterns in diabetes in pregnancy: a longitudinal study, Isr. J. Med. Sci.,   27, 516.

116.  Schaefer-Graf, U.M., Kjos, S.L., Kilavuz, O., Plagemann, A., Brauer, M., Dudenhausen, J.W., and Vetter, K., 2003, Determinants of fetal growth at different periods of pregnancies complicated by gestational diabetes mellitus or impaired glucose tolerance, Diabetes Care,   26, 193. 

117.  Yudkin, J.S., Phillips, D.I., and Stanner, S., 1997, Proteinuria and progressive renal disease: birth weight and microalbuminuria, Nephrol. Dial. Transplant.,     2, 10.

118.  Wollmann, H.A., 1998, Intrauterine growth restriction: definition and etiology,  Horm. Res.,  49 Suppl 2, 1.

119.  Spinillo, A., Capuzzo, E., Piazzi, G., Nicola, S., Colonna, L., and Iasci, A., 1994, Maternal high-risk factors and severity of growth deficit in small for gestational age infants, Early Hum. Dev.,  38, 35.

120.  Cnattingius, S., Mills, J.L., Yuen, J., Eriksson, O., and Salonen, H., 1997, The paradoxical effect of smoking in preeclamptic pregnancies: Smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction, Am. J. Obstet. Gynecol.,177, 156.

121.  De Farias Aragao, V.M., Barbieri, M.A., Moura Da Silva, A.A., Bettiol, H., and Ribeiro, V.S., 2005, Risk factors for intrauterine growth restriction: a comparison between two Brazilian cities, Pediatr. Res.    57(5 Pt 1), 674.

122.  Horta, B.L., Victora, C.G., Menezes, A.M., Halpern, R., and Barros, F.C., 1997, Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking, Paediatr. Perinat. Epidemiol.,    11, 140.

123.  Shu, X.O., Hatch, M.C., Mills, J., Clemens, J., and Susser, M., 1995, Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study, Epidemiology,    6, 115.

124.  Secker-Walker, R.H., and Vacek, P.M., 2003, Relationships between cigarette smoking during pregnancy, gestational age, maternal weight gain, and infant birthweight,  Addict. Behavior,   28, 55. 

125.  Marcoux, S., Brisson, J., and Fabia, J., 1989, The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension, Am. J. Epidemiol.,  130, 950.

126.  King, J.C., and Fabro, S., 1983, Alcohol consumption and cigarette smoking: effect on pregnancy, Clin. Obstet. Gynecol.,   26, 437.

127.  Sood, B., Delaney-Black, V., Covington, C., Nordstrom-Klee, B., Ager, J., Templin, T., Janisse, J., Martier, S., and Sokol, R.J., 2001, Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: 1. Dose-response effect, Pediatrics,  108, E34.

128.  Lundsberg, L.S., Bracken, M.B., and Saftlas, A.F., 1997, Low-to-moderate gestational alcohol use and intrauterine growth retardation, low birthweight, and preterm delivery, Ann. Epidemiol., 7, 498.

129.  Faden, V.B., Graubard, B.I., and Dufour, M.,  1997, The relationship of drinking and birth outcome in a US national sample of expectant mothers, Paediatr. Perinat. Epidemiol.,   11, 167.

130.  Windham, G.C., Fenster, L., Hopkins, B., and Swan, S.H., 1995, The association of moderate maternal and paternal alcohol consumption with birthweight and gestational age, Epidemiology,   6, 591.

131.  Hannigan, J.H., Martier, S.S., and Naber, J.M., 1995, Independent associations among maternal alcohol consumption and infant thyroxine levels and pregnancy outcome, Alcohol Clin. Exp. Res.,  19, 135.

132.  Infante-Rivard, C., 2004, Drinking water contaminants, gene polymorphisms, and fetal growth, Environ. Health. Perspect.,   112, 1213. 

133.  Munger, R., Isacson, P., Hu, S., Burns, T., Hanson, J., Lynch, C.F., Cherryholmes, K., Van Dorpe, P., and Hausler, W.J.Jr.,  1997, Intrauterine growth retardation in Iowa communities with herbicide-contaminated drinking water supplies, Environ. Health. Perspect.,  105, 308. 

134.  Ergaz, Z., Avgil, M., and Ornoy, A., 2005, Intrauterine growth restriction-etiology and consequences: what do we know about the human situation and experimental animal models? Reprod. Toxicol.,   20, 301. 

135.  Pérez-Escamilla, R., and Pollitt, E., 1992, Causes and consequences of intrauterine growth retardation in Latin America, Bull. Pan. Am. Health Organ., 26, 128.

136.  Karim, E., and Mascie-Taylor, C.G., 1997, The association between birthweight, sociodemographic variables and maternal anthropometry in an urban sample from Dhaka, Bangladesh, Ann. Hum. Biol.,    24, 387.

137.  Leon, D.A., 1998, Fetal growth and adult disease, Eur. J. Clin. Nutr.,   52,  S72.

138.  Barker, D.J.P., 1998, In utero programming of chronic disease, Clin. Sci.,  95, 115.

139.  Henriksen, T., and Clausen, T., 2002, The fetal origins hypothesis: placental insufficiency and inheritance versus maternal malnutrition in well-nourished populations, Acta Obstet. Gynecol. Scand.,  81, 112. 

140.  Whincup, P., Cook, D., Papacosta, O., and Walker, M., 1995, Birth weight and blood pressure. cross sectional and longitudinal relations in childhood, Br. Med. J.,   311, 773.

141.  Leon, D.A., Lithell, H.O., Vågerö, D., Koupilová, I., Mohsen, R., Berglund, L., Lithell, U.B., and McKeigue, P.M.,  1998, Reduced fetal growth and increased risk of death from ischaemic heart disease. cohort study of 15000 Swedish men and women born 1915–29,   Br. Med. J.,   317, 241.

142.  Stanner, S.A., Bulmer, K., Andrès, C., Lantseva, O.E., Borodina, V., Poteen, V.V., and Judkin, J.S., 1997, Does malnutrition in utero determine diabetes and coronary heart disease in adulthood. Results from the Leningrad siege study, a cross sectional study, Br. Med. J.,  315, 1342.

143.  De Onis, M., Villar, J., and Gülmezoglu, M., 1998, Nutritional interventions to prevent intrauterine growth retardation evidence from randomized controlled trials, Eur. J. Clin. Nutr.,   52, S83.

144.  Lumey, L.H.,  Stein, A.D., and Racelli, A.C.J., 1995, Timing of prenatal starvation in women and birth weight in their first  and second offspring: the Dutch famine birth cohort study, Eur. J. Obstet. Gynecol. Reprod. Biol.,  61, 25.

145.  Rey, E., and Couturier, A., 1994, The prognosis of pregnancy in women with chronic hypertension, Am. J. Obstet. Gynecol.,   171, 410.

146.  Dekker, G.A., de Vries, J.I.P., Doelitzsch, P.M., Huijgens, P.C., von Blomberg, B.M.E., Jakobs, C., and van Geijn, H.P.,  1995, Underlying disorders associated with severe early-onset preeclampsia, Am. J. Obstet. Gynecol.,   173, 1042.

147.  Lorentzen, B., and Henriksen, T., 1998, Plasma lipids and vascular dysfunction in preeclampsia,  Semin. Reprod. Endocrinol.,   16, 33.

148.  Walker, B.R., McConnachie, A., Noon, J.P., Webb, D.J., and Watt, G.C.M., 1998, Contribution of parental blood pressure to association between low birth weight and adult high blood pressure: cross sectional study, Br. Med. J., 316, 834.

149.  Waugh, J., Perry, I.J., Halligan, A.W., deSwiet, M., Lambert, P.C., Penny, J.A., Taylor, D.J., Jones, D.R., and Shennan, A.,  2000, Birth weight and 24-h ambulatory blood pressure in non-proteinuric hypertensive pregnancy, Am. J. Obstet. Gynecol.,   183, 633.

150.  Harding, J.E., 2001, The nutritional basis for fetal origins of adult disease, Int. J. Epidemiol., 30, 15.

151.  Goldenberg, R.L., Tamura, T., Cliver, S.P., Cutter, G.R., Hoffman, H.J., and Copper, R.L., 1992, Serum folate and fetal growth retardation: a matter of compliance? Obstet. Gynecol.,  79, 719.

152.  Heinrich, U.E., 1992, Intrauterine growth retardation and familial short stature, Baillieres  Clin. Endocrinol. Metab.,   6, 589.

153. Feinberg, R.F., Kliman, H.J., and Cohen, A.W., 1991, Preeclampsia, trisomy 13, and the placental bed, Obstet. Gynecol.,   78, 505.

154.  von Kries, R., Junker, R., Oberle, D., Kosch, A., and Nowak-Gottl, U., 2001, Foetal growth restriction in children with prothrombotic risk factors, Thromb. Haemost., 86, 1012.

155.  Zoccali, C., 2002, Nephropathy associated with arterial hypertension: genes and Barker's hypothesis, G. Ital. Nefrol.,    19, 517.

156.  Akisu, M., Balim, Z., Cetin, H., Kosova, B., Yalaz, M., Topcuoglu, N., and Kultursay, N.,  2004, The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intrauterine growth restriction, Early Hum. Dev.,    78, 95.

157.  Grati, F.R., Miozzo, M., Cassani, B., Rossella, F., Antonazzo, P., Gentilin, B., Sirchia, S.M., Mori, L., Rigano, S., Bulfamante, G., Cetin, I., and Simoni, G., 2005, Fetal and placental chromosomal mosaicism revealed by QF-PCR in severe IUGR pregnancies, Placenta,    26, 10.

158.  Yamada, H., Sata, F., Saijo, Y., Kishi, R., and Minakami, H., 2005, Genetic factors in fetal growth restriction and miscarriage, Semin. Thromb. Hemost.,  31, 334. 

159.  Alexander, G.R., Kogan, M.D., Himes, J.H., Mor, J.M., and Goldenberg, R., 1999, Racial differences in birth weight for gestational age and infant mortality in extremely-low-risk US populations, Paediatr. Perinat. Epidemiol., 13, 205.

160.  Goldenberg, R.L., Tamura, T., Cliver, S.P., Cutter, G.R., Hoffman, H.J., and Davis, R.O., 1991, Maternal serum alpha 2-macroglobulin and fetal growth retardation, Obstet. Gynecol.,  78, 594.

161.  Hughson, M.D., Douglas-Denton, R., Bertram, J.F., Hoy, W.E., 2006, Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States, Kidney Int.,  69, 671. 

162.  Bissenden, J.G., Scott, P.H., Hallum, J., Mansfield, H.N., Scott, P., and Wharton, B.A., 1981, Racial variations in tests of fetoplacental function, Br. J. Obstet. Gynaecol.,    88, 109.

163.  Vialet, R., Mbaye, K., de Mouzon, J., and Spira, A., 1988, Echography in comparing the fetal growth of infants of African and European mothers, J. Gynecol. Obstet. Biol. Reprod. (Paris),  17, 1003.

164. Blankson, M.L., Goldenberg, R.L., Cutter, G., and Cliver, S.P., 1993, The relationship between maternal hematocrit and pregnancy outcome: black-white differences, J. Natl. Med. Assoc.,   85, 130.

165.  Frisbie, W.P., Biegler, M., de Turk, P., Forbes, D., and Pullum, S.G.,  1997, Racial and ethnic differences in determinants of intrauterine growth retardation and other compromised birth outcomes, Am. J. Public. Health.,    87, 1977.

166.  Frisbie, W.P., Forbes, D., and Pullum, S.G.,  1996, Compromised birth outcomes and infant mortality among racial and ethnic groups, Demography,  33,  469.

167.  Reichman, N.E., and Kenney, G.M., 1998, Prenatal care, birth outcomes and newborn hospitalization costs: patterns among Hispanics in New Jersey, Fam. Plann. Perspect.,  30,182. 

168.  Gould, J.B., Madan, A., Qin, C., and Chavez, G., 2003, Perinatal outcomes in two dissimilar immigrant populations in the United States: a dual epidemiologic paradox, Pediatrics,  111, E676.

169.  Alexander, G.R., Kogan, M.D., and Himes, J.H., 1999, 1994-1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender, Matern. Child. Health. J.,   3, 225.

170.  Singh, G.K., and Yu, S.M., 1996, Adverse pregnancy outcomes: differences between US- and foreign-born women in major US racial and ethnic groups, Am. J. Public. Health.,  86, 837. 

171.  Guendelman, S., Buekens, P., Blondel, B., Kaminski, M., Notzon, F.C., and Masuy-Stroobant, G., 1999, Birth outcomes of immigrant women in the United States, France, and Belgium,  Matern. Child. Health. J.,    3,177.

172.  Rosenberg, T.J., Garbers, S., Lipkind, H., and Chiasson, M.A., 2005, Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups,  Am. J. Public. Health.,  95, 1545. 

173.  Alexander, G.R., Kogan, M., Bader, D., Carlo, W., Allen, M., and Mor, J., 2003, US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, hispanics, and blacks, Pediatrics,    111, E61. 

174.  Barnett, E., 1995, Race differences in the proportion of low birth weight attributable to maternal cigarette smoking in a low-income population, Am. J. Health. Promot.,  10, 105.

175.  Simon, D.M., Vyas, S., Prachand, N.G., David, R.J., and Collins, J.W.Jr. 2006, Relation of maternal low birth weight to infant growth retardation and prematurity, Matern. Child. Health. J.,   10, 321.

 

(To 10.4)

176.  Tan, T.Y., and Yeo, G.S., 2005, Intrauterine growth restriction, Curr. Opin. Obstet. Gynecol.,   17, 135.

177.  Kanaka-Gantenbein, C., Mastorakos, G., and Chrousos, G.P., 2003, Endocrine-related causes and consequences of intrauterine growth retardation, Ann. N.Y. Acad. Sci.,    997, 150. 

178.  Silver, L.E., Decamps, P.J., Korst, L.M., Platt, L.D., and Castro, L.C., 2003, Intrauterine growth restriction is accompanied by decreased renal volume in the human fetus, Am. J. Obstet. Gynecol.,   188, 1320. 

179.  Zidar, N., Cavic, M.A., Kenda, R.B., Koselj, M., and Ferluga, D., 1998, Effect of intrauterine growth retardation on the clinical course and prognosis of IgA glomerulonephritis in children, Nephron,  79, 28.